Search Results

DRNO found 10 articles matching your search.

Cutting Edge Adds Custom Research Offer

In the US, pharma specialist Cutting Edge Information has launched a customized survey offering, adding to its existing proprietary databases of market data, industry executives and physicians. More

Pharma Specialist Adds Custom Service

US pharma business intelligence firm Cutting Edge Information has launched a new customized survey service which taps into its database of 350,000 executives at more than 4,000 life sciences companies worldwide. More

Research Steers Troubled Pharma Firms

Pharmaceutical companies are turning to MR departments to help them run leaner organizations in troubled economic times, according to a new report from sector specialist Cutting Edge Information. More

Research ROI Unmeasurable, Say Pharma Firms

Pharma companies are moving away from the idea of hard ROI measurement for their market research, according to a study by US-based Cutting Edge Information. 74% of surveyed companies do not attempt to calculate ROI for MR. More

Pharma Firms Add Research Staff

The world's pharmaceutical companies have been hiring market researchers at a rapid rate in the last year, according to a report from sector specialist Cutting Edge Information. Overall MR headcount is reportedly up an average of 21%. More

Pharma Firms Switch MR Funds from US

Pharmaceutical companies have decreased their US MR budgets by an average of 22.7% since last year, but increased them elsewhere in the world, according to a new study by Cutting Edge Information. More

MR Takes Lion's Share of Early Pharma Spending

Blockbuster pharmaceutical brands receive an average marketing investment of $11.7m between Pre-Clinical and Phase II – and market research dominates early phase spending, according to a report by business intelligence firm Cutting Edge Information. More

Long-term View for Drugs Firms

A new study from business research firm Cutting Edge Information reveals that top pharmaceutical companies start conducting MR an average of 6.2 years before a drug launch. The study highlights the research strategies and techniques of leading drugs companies. More

Low Investment Threatens Next Generation Drugs

Pharmaceutical companies may be starving the next generation of blockbuster drugs of the development support they need, according to a study by business intelligence firm Cutting Edge Information. More than $100bn worth of products face patent expiration over the next three years, says the study. More

MR Spending Habits of Pharmaceuticals Giants

Major pharmaceutical companies typically spend around $3 - 4 million on pre-launch research for a product, and spend an average of $710,000 on post-launch or 'in-line' product research, according to a new report from US pharmaceutical intelligence firm Cutting Edge Information. More

Register (free) for Daily Research News